Welcome to the ICH official website

The International Conference on Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use (ICH) is unique in bringing together the regulatory authorities and pharmaceutical industry of Europe, Japan and the US to discuss scientific and technical aspects of drug registration. Since its inception in 1990, ICH has evolved, through its ICH Global Cooperation Group, to respond to the increasingly global face of drug development, so that the benefits of international harmonisation for better global health can be realised worldwide. ICH's mission is to achieve greater harmonisation to ensure that safe, effective, and high quality medicines are developed and registered in the most resource-efficient manner. Download the ICH 20th Anniversary Publication

Discover ICH Products

  • Quality Guidelines

    Harmonisation achievements in the Quality area include pivotal milestones such as the conduct of stability studies, defining relevant thresholds for impurities... (more)

  • Safety Guidelines

    ICH has produced a comprehensive set of safety guidelines to uncover potential risks like carcinogenicity, genotoxicity and reprotoxicity. A recent breakthrough has been a non-clinical testing strategy ... (more)

  • Efficacy Guidelines

    The work carried out by ICH under the Efficacy heading is concerned with the design, conduct, safety and reporting of clinical trials. It also covers novel types of medicines... (more)

  • Multidisciplinary Guidelines

    Those are the cross-cutting topics which do not fit uniquely into one of the Quality, Safety and Efficacy categories.  It includes the ICH medical terminology (MedDRA)... (more)

  • M4: CTD

    The agreement to assemble all the Q, S, and E information in a common format (called CTD - Common Technical Document ) has revolutionized the regulatory review processes... (more)

  • M1: MedDRA

    MedDRA is a rich and highly specific standardised medical terminology developed by ICH to facilitate sharing of regulatory information internationally for medical products used by humans. ... (more)

ICH Training

China ICH Study Group workshop on ICH M Guidelines

25-26 October 2012, Beijing, China

DIA ICH endorsed training on E2 Pharmacovigilance Guidelines

22-23 October 2012, Midrand (Johannesburg), South Africa

Help to Shape the ICH Guidelines

 

by responding to one of our consultations. Your contribution will then be considered by the relevant ICH Working Group.

 

Draft Guidelines

Q&A Documents

Recent News

3 June 2013

Press release MedDRA Management Board meeting La Hulpe, Belgium, 1-2 June

 

The Board welcomed to a special session representatives of Regional Harmonisation...

7 February 2013

ICH M7 Guideline reaches Step 2 of the ICH Process

 

M7 Guideline on Assessment and Control of DNA Reactive (Mutagenic) Impurities...

20 December 2012

ICH E2C(R2) Guideline reaches Step 4 of the ICH Process

 

The purpose of this revised guidance is to ensure that the periodic safety update reports